Auxilium Pharmaceuticals Inc (AUXL) financial statements (2020 and earlier)

Company profile

Business Address 640 LEE ROAD
CHESTERBROOK, PA 19087
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2014
TTM
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 71157
Cash and cash equivalents 4836
Short-term investments 23122
Receivables 8956
Inventory, net of allowances, customer advances and progress billings 4222
Inventory 4222
Prepaid expense and other current assets4
Deferred tax assets 15 
Other undisclosed current assets 212
Total current assets: 239241
Noncurrent Assets
Inventory, Noncurrent 5550
Property, plant and equipment 3529
Long-term investments and receivables  1
Long-term investments  1
Intangible assets, net (including goodwill) 854
Goodwill 104 
Intangible assets, net (excluding goodwill) 749 
Other noncurrent assets 19
Prepaid expense and other noncurrent assets6
Total noncurrent assets: 96387
TOTAL ASSETS: 1,201327
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 14399
Accounts payable 14
Accrued liabilities 12281
Employee-related liabilities 2015
Debt 14 
Deferred revenue and credits 313
Other undisclosed current liabilities 36(15)
Total current liabilities: 19697
Noncurrent Liabilities
Long-term debt and lease obligation 242 
Long-term debt, excluding current maturities 242 
Liabilities, other than long-term debt 5630
Deferred revenue and credits 3230
Deferred tax liabilities, net 24 
Other undisclosed noncurrent liabilities 456 
Total noncurrent liabilities: 75330
Total liabilities: 950128
Stockholders' equity
Stockholders' equity attributable to parent, including: 251200
Treasury stock, value (3)(3)
Additional paid in capital 595525
Accumulated other comprehensive loss (0)(1)
Accumulated deficit (340)(322)
Other undisclosed stockholders' equity attributable to parent 00
Total stockholders' equity: 251200
TOTAL LIABILITIES AND EQUITY: 1,201327

Income statement (P&L) ($ in millions)

9/30/2014
TTM
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
 401395
Cost of revenue
(Cost of Goods and Services Sold)
 (112)(78)
Gross profit: 289317
Operating expenses (359)(231)
Other undisclosed operating income 2 
Operating income (loss): (68)85
Nonoperating income 01
Investment income, nonoperating  1
Other nonoperating income 0 
Interest and debt expense (29)(0)
Income (loss) from continuing operations before income taxes: (96)86
Income tax benefit 78 
Net income (loss) available to common stockholders, diluted: (18)86

Comprehensive Income ($ in millions)

9/30/2014
TTM
12/31/2013
12/31/2012
Net income (loss): (18)86
Comprehensive income (loss): (18)86
Other undisclosed comprehensive income, net of tax, attributable to parent 00
Comprehensive income (loss), net of tax, attributable to parent: (18)86

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: